{"id":"https://openalex.org/W1966476566","doi":"https://doi.org/10.1097/cad.0b013e3283475f70","title":"Primary human tumor xenografted models (\u2018tumorgrafts\u2019) for good management of patients with cancer","display_name":"Primary human tumor xenografted models (\u2018tumorgrafts\u2019) for good management of patients with cancer","alternate_titles":[],"publication_year":2011,"publication_date":"2011-05-26","ids":{"openalex":"https://openalex.org/W1966476566","doi":"https://doi.org/10.1097/cad.0b013e3283475f70","mag":"1966476566","pmid":"https://pubmed.ncbi.nlm.nih.gov/21623183"},"language":"en","primary_location":{"id":"doi:10.1097/cad.0b013e3283475f70","doi":"https://doi.org/10.1097/cad.0b013e3283475f70","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cad.0b013e3283475f70","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1966476566"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089229030","display_name":"Didier Decaudin","orcid":"https://orcid.org/0000-0003-2254-0043","observed_orcids":["https://orcid.org/0000-0003-2254-0043"]},"institutions":[{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Didier Decaudin","raw_affiliation_strings":["Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, Paris, France. didier.decaudin@curie.net","Department of Medical Oncology, Institut Curie, Paris, France","e-mail: [email\u00a0protected]","fax: +33 1 53 10 40 11","to Didier Decaudin, MD, PhD, Institut Curie, 26 Rue d'Ulm, Cedex 05, 75248 Paris, France Tel: +33 1 44 32 46 90"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, Paris, France. didier.decaudin@curie.net","institution_ids":["https://openalex.org/I80043"]},{"raw_affiliation_string":"Department of Medical Oncology, Institut Curie, Paris, France","institution_ids":["https://openalex.org/I80043"]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +33 1 53 10 40 11","institution_ids":[]},{"raw_affiliation_string":"to Didier Decaudin, MD, PhD, Institut Curie, 26 Rue d'Ulm, Cedex 05, 75248 Paris, France Tel: +33 1 44 32 46 90","institution_ids":["https://openalex.org/I80043"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5089229030"],"corresponding_institution_ids":["https://openalex.org/I80043"],"apc_list":null,"apc_paid":null,"fwci":3.7298,"has_fulltext":false,"cited_by_count":53,"citation_normalized_percentile":{"value":0.93829381,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"22","issue":"9","first_page":"827","last_page":"841"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.961899995803833,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.961899995803833,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.009700000286102295,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11149","display_name":"Veterinary Oncology Research","score":0.005100000184029341,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/human-tumor-xenografts","display_name":"human tumor xenografts","score":0.8980000019073486},{"id":"https://openalex.org/keywords/preclinical-cancer-models","display_name":"preclinical cancer models","score":0.9549999833106995},{"id":"https://openalex.org/keywords/model-validation","display_name":"model validation","score":0.6320000290870667},{"id":"https://openalex.org/keywords/anticancer-drug-development","display_name":"anticancer drug development","score":0.7459999918937683},{"id":"https://openalex.org/keywords/genetically-engineered-mouse-models","display_name":"genetically engineered mouse models","score":0.6179999709129333},{"id":"https://openalex.org/keywords/human-cancer-cell-lines","display_name":"human cancer cell lines","score":0.6349999904632568},{"id":"https://openalex.org/keywords/immunodeficient-mice","display_name":"immunodeficient mice","score":0.8289999961853027},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.6890000104904175},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.8629999756813049},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.7229999899864197}],"concepts":[{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.7099039554595947},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6302523612976074},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.5645884871482849},{"id":"https://openalex.org/C2994543053","wikidata":"https://www.wikidata.org/wiki/Q7239206","display_name":"Preclinical testing","level":2,"score":0.5384352803230286},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5148967504501343},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.43744444847106934},{"id":"https://openalex.org/C3019816032","wikidata":"https://www.wikidata.org/wiki/Q2575340","display_name":"Cancer treatment","level":3,"score":0.4188949167728424},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4100317060947418},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.39106500148773193},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3878787159919739},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3585658073425293},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3421159088611603},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2480468451976776},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.22697147727012634},{"id":"https://openalex.org/C19527891","wikidata":"https://www.wikidata.org/wiki/Q1120908","display_name":"Medical physics","level":1,"score":0.20278123021125793},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1756414771080017}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016513","descriptor_name":"Mice, SCID","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/cad.0b013e3283475f70","doi":"https://doi.org/10.1097/cad.0b013e3283475f70","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cad.0b013e3283475f70","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},{"id":"pmid:21623183","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21623183","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W2033419936"],"related_works":["https://openalex.org/W1980361000","https://openalex.org/W1550884756","https://openalex.org/W2015187541","https://openalex.org/W1909696304","https://openalex.org/W12764995","https://openalex.org/W2120191503","https://openalex.org/W2166783527","https://openalex.org/W2057494314","https://openalex.org/W159782486","https://openalex.org/W2318451339"],"abstract_inverted_index":{"The":[0,105,174],"treatment":[1],"of":[2,10,14,19,34,55,70,107,114,138,142,145,176,191,194],"cancer":[3,72],"is":[4,58,122,179],"continually":[5],"improving":[6],"as":[7,103,159],"a":[8,11,31,110,134],"result":[9],"better":[12],"understanding":[13],"oncogenesis":[15],"and":[16,36,41,91,147,165,189],"the":[17,49,63,119,126,143,183,187],"development":[18,65],"new":[20],"targeted":[21],"compounds.":[22],"Early":[23],"clinical":[24,150],"trials":[25],"evaluating":[26],"such":[27,158],"candidate":[28],"compounds":[29,57],"require":[30],"large":[32],"number":[33],"patients,":[35],"are":[37,74],"expensive,":[38],"time":[39],"consuming,":[40],"expose":[42],"patients":[43,96,155],"to":[44,123,161,181],"certain":[45],"risks.":[46],"To":[47],"select":[48],"most":[50],"effective":[51],"molecules,":[52],"preclinical":[53,71,78,192],"investigation":[54],"antitumor":[56],"an":[59],"important":[60],"step":[61],"in":[62,77,117,154],"drug":[64],"process.":[66],"Three":[67],"main":[68],"categories":[69],"models":[73,193],"generally":[75],"used":[76,200],"investigations,":[79],"namely":[80],"genetically":[81],"engineered":[82],"models,":[83],"xenografts":[84],"derived":[85],"from":[86,95],"human":[87,92,131,195],"tumor":[88,93],"cell":[89],"lines,":[90],"fragments":[94],"implanted":[97],"directly":[98],"into":[99],"immunodeficient":[100],"mice,":[101],"known":[102],"tumorgrafts.":[104],"establishment":[106,188],"tumorgrafts":[108],"constitutes":[109],"long-term":[111],"process":[112],"consisting":[113],"various":[115],"steps,":[116],"which":[118],"final":[120],"objective":[121],"show":[124],"that":[125,197],"validated":[127],"model":[128],"accurately":[129],"reproduces":[130],"cancer,":[132,157],"with":[133,156],"high":[135],"predictive":[136],"value":[137],"therapeutic":[139],"efficacy":[140],"(regardless":[141],"type":[144],"treatment),":[146],"closely":[148],"mimics":[149],"situations":[151],"frequently":[152],"observed":[153],"resistance":[160],"standard":[162],"treatments,":[163],"metastases,":[164],"relapse":[166],"after":[167],"initial":[168],"therapies":[169],"(involving":[170],"residual":[171],"tumor-initiating":[172],"cells).":[173],"aim":[175],"this":[177],"study":[178],"therefore":[180],"discuss":[182],"proposed":[184],"criteria":[185],"for":[186,201],"validation":[190],"cancers":[196],"should":[198],"be":[199],"further":[202],"pharmacological":[203],"assessments.":[204]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1966476566","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
